MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 11, 2006; DOI: 10.1124/mol.106.027326


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.027326v1
70/4/1358    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tumkosit, P.
Right arrow Articles by Lindstrom, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tumkosit, P.
Right arrow Articles by Lindstrom, J. M.


Received for publication June 1, 2006.
Revised July 3, 2006.
Accepted for publication July 11, 2006.

{beta}3 Subunits Promote Expression and Nicotine- Induced Upregulation of Human Nicotinic {alpha}6* AChRs Expressed in Transfected Cell Lines

Prem Tumkosit 1, Alexander Kuryatov 2, Jie Luo 1, Jon M. Lindstrom 1*

1 University of Pennsylvania Medical School 2 University of Pennsylvania

* Address correspondence to: E-mail: jslkk{at}mail.med.upenn.edu

Abstract

Nicotinic acetylcholine receptors (AChRs) containing & [alpha]6 subunits are typically found at aminergic nerve endings where they play important roles in nicotine addiction and Parkinson's disease. {alpha}6* AChRs usually contain {beta}3 subunits. {beta}3 subunits are presumed to assemble only in the accessory subunit position within AChRs where they do not participate in forming ACh binding sites. Assembly of subunits in the accessory position may be a critical final step in assembly of mature AChRs. Human {alpha}6 AChRs subtypes were permanently transfected into human tsA201 HEK cell lines. {alpha}6{beta}2{beta}3 and {alpha}6{beta}4& [beta]3 cell lines were found to express much larger amounts of AChRs and were more sensitive to nicotine- induced increase in the amount of AChRs than were & [alpha]6{beta}2 or {alpha}6{beta}4 cell lines. The increased sensitivity to nicotine-induced upregulation was not due to a {beta}3 induced increase in affinity for nicotine, but probably due to a direct effect on assembly of AChR subunits. HEK cells express only a small amount of mature {alpha}6{beta}2 AChRs, but many of these are on the cell surface. This contrasts with Xenopus oocytes which express a large amount of incorrectly assembled {alpha}6{beta}2 subunits which bind cholinergic ligands but form large amorphous intracellular aggregates. mAbs were made to the {alpha} 6 and {beta}3 subunits to aid in the characterization of these AChRs. The {alpha}6 mAbs bind to epitopes C- terminal of the extracellular domain. These data demonstrate that both cell type and the accessory subunit {beta}3 can play important roles in {alpha}6* AChR expression, stability, and upregulation by nicotine.


Key words: Nicotinic cholinergic, Receptor binding studies


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
X. A. Perez, T. Bordia, J. M. McIntosh, S. R. Grady, and M. Quik
Long-Term Nicotine Treatment Differentially Regulates Striatal {alpha}6{alpha}4{beta}2* and {alpha}6(Non{alpha}4){beta}2* nAChR Expression and Function
Mol. Pharmacol., September 1, 2008; 74(3): 844 - 853.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Kuryatov, J. Onksen, and J. Lindstrom
Roles of Accessory Subunits in {alpha}4{beta}2* Nicotinic Receptors
Mol. Pharmacol., July 1, 2008; 74(1): 132 - 143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Walsh, A. P. Govind, R. Mastro, J. C. Hoda, D. Bertrand, Y. Vallejo, and W. N. Green
Up-regulation of Nicotinic Receptors by Nicotine Varies with Receptor Subtype
J. Biol. Chem., March 7, 2008; 283(10): 6022 - 6032.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. M. Drenan, R. Nashmi, P. Imoukhuede, H. Just, S. McKinney, and H. A. Lester
Subcellular Trafficking, Pentameric Assembly, and Subunit Stoichiometry of Neuronal Nicotinic Acetylcholine Receptors Containing Fluorescently Labeled {alpha}6 and 3 Subunits
Mol. Pharmacol., January 1, 2008; 73(1): 27 - 41.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Nashmi, C. Xiao, P. Deshpande, S. McKinney, S. R. Grady, P. Whiteaker, Q. Huang, T. McClure-Begley, J. M. Lindstrom, C. Labarca, et al.
Chronic Nicotine Cell Specifically Upregulates Functional {alpha}4* Nicotinic Receptors: Basis for Both Tolerance in Midbrain and Enhanced Long-Term Potentiation in Perforant Path
J. Neurosci., August 1, 2007; 27(31): 8202 - 8218.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. C. Perry, D. Mao, A. B. Gold, J. M. McIntosh, J. C. Pezzullo, and K. J. Kellar
Chronic Nicotine Differentially Regulates {alpha}6- and beta3-Containing Nicotinic Cholinergic Receptors in Rat Brain
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 306 - 315.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
O. Salminen, J. A. Drapeau, J. M. McIntosh, A. C. Collins, M. J. Marks, and S. R. Grady
Pharmacology of {alpha}-Conotoxin MII-Sensitive Subtypes of Nicotinic Acetylcholine Receptors Isolated by Breeding of Null Mutant Mice
Mol. Pharmacol., June 1, 2007; 71(6): 1563 - 1571.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Tapia, A. Kuryatov, and J. Lindstrom
Ca2+ Permeability of the ({alpha}4)3(beta2)2 Stoichiometry Greatly Exceeds That of ({alpha}4)2(beta2)3 Human Acetylcholine Receptors
Mol. Pharmacol., March 1, 2007; 71(3): 769 - 776.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics